Raymond James raised the firm’s price target on Skyward Specialty Insurance to $30 from $28 and keeps a Strong Buy rating on the shares. The firm believes Skyward could continue to report 10%+ GWP growth through 2024 and sees mid-teens operating ROBEs through 2025 due in part to strong premium growth, improving underlying margins, and eventual increases in NII, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on SKWD:
- Skyward Specialty adds Ashe to its board of directors
- Skyward Specialty Welcomes Gena Ashe to Board of Directors
- Skyward Specialty Insurance price target raised to $28 from $27 at BMO Capital
- Skyward Specialty Insurance price target raised to $32 from $30 at JMP Securities
- Skyward Specialty Insurance reports Q2 adjusted EPS 42c , consensus 38c